Innovations in Hearing Accessibility and Technology (IHAT) Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorUniversity of Colorado, Denver

About this trial

The research will explore outcomes of different service delivery models of over-the-counter (OTC) hearing aids by comparing them to prescription hearing aids fitted by specialists in individuals with mild to moderate hearing loss. The investigators will examine how each type affects users' experiences, behavior, thinking skills, and brain activity related to hearing. Additionally, the study will focus on what types of people prefer each hearing aid option, what helps or hinders these choices, and compare the costs of four different service options. This approach will help transition from research findings into real-world practice, providing useful information for healthcare providers and policymakers about OTC hearing aid options.

Eligibility criteria

Qualifiers

Adult onset, bilateral, mild-to-moderate sensorineural hearing loss documented by audiological evaluation

Aged 40 years or older

No previous HA experience greater than 3 months

Able to read and understand patient education materials

Disqualifiers

Hearing loss that is too severe for OTC HAs

Middle ear disorders or conductive pathology present

Asymmetrical hearing loss

Diagnosed neurological condition such as dementia or Parkinson's disease or a score lower than 25 on the MOCA

Trial design

Treatments tested in this trial

  • HA-HCP
  • OTC-HCP
  • OTC-R
  • OTC-SF

Treatment groups

280 Participants
are divided into 4 treatment groups

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator